Oct 4, 2025
Awarded for excellence in longevity medicine and voted Best Innovation at the 2025 APLS Summit
We’re honored to share that Circulate Health has been recognized by the Asian Pacific Longevity Medicine International Summit as one of the Longevity Breakthrough Award winners for 2025.
Our recognition in the Medical Interventions category celebrates Circulate Health’s continued innovation in advancing therapeutic approaches that improve cellular function and extend healthspan. The award highlights our dedication to evidence-based protocols, precision treatment design, and our vision for accessible, proactive, longevity medicine.
In addition to this category win, Circulate Health received the distinguished honor of being selected as the “Most Popular Innovation” by interconference vote—a recognition from peers and experts across the global longevity ecosystem.
Hosted by the Asia-Pacific Longevity Society (APLS) and the Longevity Awards Council, the 2025 Summit brought together thought leaders, clinicians, and researchers to showcase advancements in aging science, regenerative medicine, and preventive healthcare. This award represents not only a milestone for our company, but also a validation of our mission to make advanced, scientific-based longevity care more personalized, data-informed, and accessible.
We’re deeply grateful to the APLS community, our clinical partners, and the patients who inspire us every day to continue pushing the boundaries of what’s possible in human healthspan.